Market Tracker

03/24 5:16pm ET

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

3.01
Delayed Data
As of 3:59pm ET
 -0.01 / -0.33%
Today’s Change
2.83
Today|||52-Week Range
9.02
-26.23%
Year-to-Date

Today’s Trading

Previous close3.02
Today’s open3.03
Day’s range2.96 - 3.06
Volume2,216,137
Average volume (3 months)3,224,676
Market cap$394.3M
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)+9.02%
Earnings growth (this year)--
Earnings growth (next 5 years)+5.61%
Revenue growth (last year)+61.64%
P/E ratioNM
Price/Sales3.54
Price/Book--

Competitors

 Today’s
change
Today’s
% change
OTICOtonomy Inc-0.25-1.91%
CNCEConcert Pharmaceutic...-0.48-2.71%
ADMSAdamas Pharmaceutica...0.000.00%
TLGTTeligent Inc-0.04-0.55%
Data as of 3:59pm ET, 03/24/2017

Financials

Next reporting dateMay 16, 2017
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$144.3M
Annual profit (last year)-$151.7M
Net profit margin-105.18%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Richard Peters
Head-
Corporate Operations
William M. McClements
Corporate headquarters
Cambridge, Massachusetts

Forecasts